Literature DB >> 22530854

Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).

G Nagel1, T Bjørge, T Stocks, J Manjer, G Hallmans, M Edlinger, C Häggström, A Engeland, D Johansen, A Kleiner, R Selmer, H Ulmer, S Tretli, H Jonsson, H Concin, P Stattin, A Lukanova.   

Abstract

BACKGROUND: Little is known about the associations of metabolic aberrations with malignant melanoma (MM) and nonmelanoma skin cancer (NMSC).
OBJECTIVES: To assess the associations between metabolic factors (both individually and combined) and the risk of skin cancer in the large prospective Metabolic Syndrome and Cancer Project (Me-Can).
METHODS: During a mean follow-up of 12 years of the Me-Can cohort, 1728 (41% women) incident MM, 230 (23% women) fatal MM and 1145 (33% women) NMSC were identified. Most NMSC cases (76%) were squamous cell carcinoma (SCC) (873, 33% women). Hazard ratios (HRs) were estimated by Cox proportional hazards regression for quintiles and standardized z-scores (with a mean of 0 and SD of 1) of body mass index (BMI), blood pressure, glucose, cholesterol, triglycerides and for a combined metabolic syndrome score. Risk estimates were corrected for random error in the measurements.
RESULTS: Blood pressure per unit increase of z-score was associated with an increased risk of incident MM cases in men and women [HR 1·17, 95% confidence interval (CI) 1·04-1·31 and HR 1·18, 95% CI 1·03-1·36, respectively] and fatal MM cases among women (HR 2·39, 95% CI 1·58-3·64). In men, all quintiles for BMI above the reference were associated with a higher risk of incident MM. In women, SCC NMSC risk increased across quintiles for glucose levels (P-trend 0·02) and there was a trend with triglyceride concentration (P-trend 0·09).
CONCLUSION: These findings suggest that mechanisms linked to blood pressure may be involved in the pathogenesis of MM. SCC NMSC in women could be related to glucose and lipid metabolism.
© 2012 The Authors. BJD © 2012 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2012        PMID: 22530854     DOI: 10.1111/j.1365-2133.2012.10974.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

Review 1.  The links between insulin resistance, diabetes, and cancer.

Authors:  Etan Orgel; Steven D Mittelman
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

2.  Obesity and risks for malignant melanoma and non-melanoma skin cancer: results from a large Danish prospective cohort study.

Authors:  Camilla Præstegaard; Susanne K Kjær; Jane Christensen; Anne Tjønneland; Jytte Halkjær; Allan Jensen
Journal:  J Invest Dermatol       Date:  2014-10-07       Impact factor: 8.551

3.  Body mass index, height and early-onset basal cell carcinoma in a case-control study.

Authors:  Yanchang Zhang; Brenda Cartmel; Courtney C Choy; Annette M Molinaro; David J Leffell; Allen E Bale; Susan T Mayne; Leah M Ferrucci
Journal:  Cancer Epidemiol       Date:  2016-12-28       Impact factor: 2.984

4.  Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Sofia Christakoudi; Artemisia Kakourou; Georgios Markozannes; Ioanna Tzoulaki; Elisabete Weiderpass; Paul Brennan; Marc Gunter; Christina C Dahm; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Anne-Laure Madika; Gianluca Severi; Verena Katzke; Tilman Kühn; Manuela M Bergmann; Heiner Boeing; Anna Karakatsani; Georgia Martimianaki; Paschalis Thriskos; Giovanna Masala; Sabina Sieri; Salvatore Panico; Rosario Tumino; Fulvio Ricceri; Antonio Agudo; Daniel Redondo-Sánchez; Sandra M Colorado-Yohar; Olatz Mokoroa; Olle Melander; Tanja Stocks; Christel Häggström; Sophia Harlid; Bas Bueno-de-Mesquita; Carla H van Gils; Roel C H Vermeulen; Kay-Tee Khaw; Nicholas J Wareham; Tammy Y N Tong; Heinz Freisling; Mattias Johansson; Hannah Lennon; Dagfinn Aune; Elio Riboli; Dimitrios Trichopoulos; Antonia Trichopoulou; Konstantinos K Tsilidis
Journal:  Int J Cancer       Date:  2019-08-20       Impact factor: 7.396

Review 5.  Skin and metabolic syndrome: A review of the possible associations.

Authors:  Neda Adibi; Reza M Robati
Journal:  J Res Med Sci       Date:  2021-02-27       Impact factor: 1.852

6.  Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2.

Authors:  Gretchen M Alicea; Vito W Rebecca; Aaron R Goldman; Mitchell E Fane; Stephen M Douglass; Reeti Behera; Marie R Webster; Curtis H Kugel; Brett L Ecker; M Cecilia Caino; Andrew V Kossenkov; Hsin-Yao Tang; Dennie T Frederick; Keith T Flaherty; Xiaowei Xu; Qin Liu; Dmitry I Gabrilovich; Meenhard Herlyn; Ian A Blair; Zachary T Schug; David W Speicher; Ashani T Weeraratna
Journal:  Cancer Discov       Date:  2020-06-04       Impact factor: 38.272

7.  Height and bone mineral density are associated with naevus count supporting the importance of growth in melanoma susceptibility.

Authors:  Simone Ribero; Daniel Glass; Abraham Aviv; Timothy David Spector; Veronique Bataille
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

8.  The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea.

Authors:  Dongwoo Kim; Seok-Jun Yoon; Young-Hoon Gong; Young Ae Kim; Hye-Young Seo; Jihyun Yoon; A-Rim Kim
Journal:  J Prev Med Public Health       Date:  2015-07-20

9.  Metabolic syndrome and skin: psoriasis and beyond.

Authors:  Tanmay Padhi
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

10.  Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.

Authors:  Xiao-li Wei; Miao-zhen Qiu; Huan-xin Lin; Ying Zhang; Jian-xin Liu; Hong-mei Yu; Wei-ping Liang; Ying Jin; Chao Ren; Ming-ming He; Wei-wei Chen; Hui-yan Luo; Zhi-qiang Wang; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Rui-hua Xu
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.